Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Artificial nucleases comprising engineered cleavage half-domains

Artificial nucleases comprising engineered cleavage half-domains

US Patent 11725218 · Granted Aug 15, 2023

Estimated economic value: $902,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR-cas9 system and uses thereof2025
Compositions for linking DNA-binding domains and cleavage domains2024
Regulation of gene expression using engineered nucleases2023
Engineered target specific base editors2023
Engineered target specific nucleases2023
Methods and compositions for treating Huntington's Disease2023
DNA-binding proteins and uses thereof2023
Methods and compositions for treating hemophilia2023
Compositions for linking DNA-binding domains and cleavage domains2023
Methods and compositions for treatment of a genetic condition2022
Engineered target specific nucleases2022
Methods and compositions for integration of an exogenous sequence within the gen2021